Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice.

@article{Bentoucha2001ActivitiesON,
  title={Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice.},
  author={Abdelhalim Bentoucha and J{\'e}r{\^o}me Robert and Herv{\'e} Dega and Nacer Lounis and Vincent Jarlier and Jacques H. Grosset},
  journal={Antimicrobial agents and chemotherapy},
  year={2001},
  volume={45 11},
  pages={3109-12}
}
Mice infected in the left hind footpad with 5 log(10) acid-fast bacilli of Mycobacterium ulcerans were divided into an untreated control group and 17 treatment groups that received one of the following regimens for 4 weeks (all doses in milligrams per kilogram): 100 mg of azithromycin (AZM), 100 mg of clarithromycin (CLR), or 50 mg of AZM for a duration of 5 days a week (daily), three times a week, or once weekly. In addition, the following regimens were administered daily: 100 mg of… CONTINUE READING
29 Citations
20 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 29 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Approche thérapeutique des infections à Mycobacterium ulcerans

  • H. Darie, S. Djakeaux, A. Cautoclaud
  • Bull. Soc. Pathol
  • 1994

Similar Papers

Loading similar papers…